Anogenital psoriasis: literature review and clinical case
- Authors: Khryanin A.A.1,2, Alyavi S.F.3, Sokolovskaya A.V.1, Chernikova E.V.1, Rakhmatov A.B.4
-
Affiliations:
- Novosibirsk State Medical University
- RPO “Association of Obstetricians-Gynecologists and Dermatovenerologists”
- Tashkent State Dental Institute
- Republican Specialized Scientific and Practical Medical Center of Dermatology, Venereology and Cosmetology
- Issue: Vol 32, No 5 (2025)
- Pages: 22-31
- Section: Reviews
- URL: https://journals.rcsi.science/2073-4034/article/view/316488
- DOI: https://doi.org/10.18565/pharmateca.2025.5.22-31
- ID: 316488
Cite item
Abstract
Psoriasis is one of the most common dermatological diseases in the world. With a global prevalence of 2–5%, psoriasis can affect all age groups of the population. At the same time, the disease has a significant negative impact on the quality of life of patients, especially when the skin is affected in the anogenital area. The prevalence of isolated anogenital psoriasis (AGP) is estimated at 2 to 5% of all patients with psoriasis. However, generalized plaque or intertriginous psoriasis also affects the genital skin in 29–40% of cases. In addition, the prevalence of AGP is probably underestimated due to the reluctance of both patients and health care providers to discuss anogenital localization and quality of life. As a rule, AGP is associated with significant general and sexual quality of life impairments, higher rates of depression. Sexual dysfunction, decreased frequency of sexual activity and avoidance of intimate relationships are the result of not only objective symptoms (e.g., cracks or pain during/after sexual activity) but also psychosocial effects (embarrassment, fear of stigmatization). It should be noted that AGP symptoms affect the patient’s daily life, social, psychological and work aspects of life. The authors dwell in detail on the features of clinical manifestations of AGP, illustrating them with examples from their own practice. Particular attention in the review is paid to methods of topical and systemic treatment of AGP (including genetically engineered biological drugs). The authors conclude that AGP is often left without due attention, and timely prescription of therapy leads to a significant improvement in the quality of life of patients
Full Text
##article.viewOnOriginalSite##About the authors
Aleksey A. Khryanin
Novosibirsk State Medical University; RPO “Association of Obstetricians-Gynecologists and Dermatovenerologists”
Author for correspondence.
Email: khryanin@mail.ru
ORCID iD: 0000-0001-9248-8303
Dr. Sci.(Med.), Professor, Department of Dermatovenereology and Cosmetology; President
Russian Federation, Novosibirsk; NovosibirskSaidnairkhon F. Alyavi
Tashkent State Dental Institute
Email: khryanin@mail.ru
ORCID iD: 0009-0003-4128-0387
Cand. Sci. (Med.), Associate Professor, Department of Dermatovenereology and Cosmetology
Uzbekistan, TashkentAsya V. Sokolovskaya
Novosibirsk State Medical University
Email: khryanin@mail.ru
ORCID iD: 0000-0002-3131-7874
Cand. Sci. (Med.), Associate Professor, Department of Dermatovenereology and Cosmetology
Russian Federation, NovosibirskEvgeniya V. Chernikova
Novosibirsk State Medical University
Email: khryanin@mail.ru
ORCID iD: 0000-0002-9297-6064
Cand. Sci. (Med.), Associate Professor, Department of Dermatovenereology and Cosmetology
Russian Federation, NovosibirskAkram B. Rakhmatov
Republican Specialized Scientific and Practical Medical Center of Dermatology, Venereology and Cosmetology
Email: khryanin@mail.ru
ORCID iD: 0009-0005-7416-1223
Dr. Sci.(Med.), Professor
Uzbekistan, TashkentReferences
- Griffiths C.E.M., Armstrong A.W., Gudjonsson J.E., Barker J.N.W.N. Psoriasis. Lancet. 2021;397(10281):1301–1315. https://dx.doi.org/10.1016/S0140-6736(20)32549-6
- Аляви С.Ф., Рахматов А.Б. Значение системы оксида азота в развитии псориаза. Фарматека. 2023;8(30):67–71. [Alyavi S.F., Rakhmatov A.B. Importance of the nitric oxide system in the development of psoriasis. Farmateka. 2023;30(8):67–71. (In Russ.)]. https://dx.doi.org/10.18565/pharmateca.2023.8.67-71
- World Health Organization. Global report on psoriasis. World Health Organization, 2016. [Google Scholar].
- Raharja A., Mahil S.K., Barker J.N. Psoriasis: a brief overview. Clin Med (Lond). 2021;21(3):170–173. https://dx.doi.org/10.7861/clinmed.2021-0257
- Feldman S.R. Disease burden and treatment adherence in psoriasis patients. Cutis. 2013;92(5):258–263.
- Yeung H., Takeshita J., Mehta N.N., et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149(10):1173–1179. https://dx.doi.org/10.1001/jamadermatol.2013.5015
- Бакулев А.Л., Фитилева Т.В., Новодережкина Е.А., и др. Псориаз: клинико-эпидемиологические особенности и вопросы терапии. Вестник дерматологии и венерологии. 2018;94:67–76. [Bakulev A.L., Fitileva T.V., Novodezerkina E.А., et al. Psoriasis: clinical and epidemiological features and therapy issues. Vestnik dermatologii i venerologii. 2018;94(3):67–76. (In Russ.)]. https://dx.doi.org/10.25208/0042-4609-2018-94-3-67-76
- Wu M., Fischer G. Adult genital psoriasis: аn updated review for clinicians. Australas J Dermatol. 2024;65(3):e1–e12. https://dx.doi.org/10.1111/ajd.14227.
- Meeuwis K.A.P., Potts Bleakman A., van de Kerkhof P.C.M., et al. Prevalence of genital psoriasis in patients with psoriasis. J Dermatolog Treat. 2018;29(8):754–760. https://dx.doi.org/10.1080/09546634.2018.1453125
- Ryan C., Sadlier M., De Vol E., et al. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. J Am Acad Dermatol. 2015;72(6):978–983. https://dx.doi.org/10.1016/j.jaad.2015.02.1127
- Beck K.M., Yang E.J., Sanchez I.M., Liao W. Treatment of genital psoriasis: a systematic review. Dermatol Ther (Heidelb). 2018;8(4):509–525. https://dx.doi.org/10.1007/s13555-018-0257-y
- Wang G., Li C., Gao T., Liu Y. Clinical analysis of 48 cases of inverse psoriasis: a hospital-based study. Eur J Dermatol. 2005;15(3):176–178.
- Meeuwis K.A., de Hullu J.A., Massuger L.F., et al. Genital psoriasis: а systematic literature review on this hidden skin disease. Acta Derm Venereol. 2011;91(1):5–11. https://dx.doi.org/10.2340/00015555-0988
- Кочергин С.Н. Новые подходы к наружной терапии псориаза генитальной локализации у мужчин. Российский журнал кожных и венерических болезней. 2016;19(2):91. [Kochergin S.N. New approaches to the topical treatment of male genital psoriasis. Russian Journal of Skin and Venereal Diseases. 2016;19(2):91–91. (In Russ)]. https://dx.doi.org/10.17816/dv37104
- Afsar F.S., Uysal S.S., Salis F.M., Calli A.O. Napkin psoriasis. Pediatr Int. 2016;58(5):420–422. https://dx.doi.org/10.1111/ped.12916
- Zamirska A., Reich A., Berny-Moreno J., et al. Vulvar pruritus and burning sensation in women with psoriasis. Acta Derm Venereol. 2008;88(2):132–135. https://dx.doi.org/10.2340/00015555-0372
- Cather J.C., Ryan C., Meeuwis K., et al. Patients’ perspectives on the impact of genital psoriasis: a qualitative study. Dermatol Ther (Heidelb). 2017;7(4):447–461. https://dx.doi.org/10.1007/s13555-017-0204-3
- Meeuwis K.A., van de Kerkhof P.C., Massuger L.F., et al. Patients’ experience of psoriasis in the genital area. Dermatology. 2012;224(3):271–276. https://dx.doi.org/10.1159/000338858
- Menter A., Korman N.J., Elmets C.A., et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137–174. https://dx.doi.org/10.1016/j.jaad. 2010.11.055.18
- Klein T. Epidemiologic survey on the prevalence of genital psoriasis and its impact on patients’ sexual life in routine care. 2022 In: 31st Congress of the European Academy of Dermatology and Venerology (EADV 2022), Milan, Italy, 7 September.
- da Silva N., von Stülpnagel C., Langenbruch A., et al. Disease burden and patient needs and benefits in anogenital psoriasis: developmental specificities for person-centred healthcare of emerging adults and adults. J Eur Acad Dermatol Venereol. 2020;34(5):1010–1018. https://dx.doi.org/10.1111/jdv.16076
- Yang E.J., Beck K.M., Sanchez I.M., et al. The impact of genital psoriasis on quality of life: a systematic review. Psoriasis (Auckl). 2018;8:41–47. https://dx.doi.org/10.2147/PTT.S169389
- Meeuwis K., Hullu J., IntHout J., et al. Genital psoriasis awareness program: physical and psychological care for patients with genital psoriasis. Acta Derm Venereol. 2015;95(2):211–216. https://dx.doi.org/10. 2340/00015555-1885
- Duarte G., Calmon H., Radel G., Oliveira M.F.P. Psoriasis and sexual dysfunction: links, risks, and management challenges. Psoriasis. 2018;8:93–99. https://dx.doi.org/10.2147/PTT.S15991652
- Yosipovitch G., Foley P., Ryan C., et al. Ixekizumab improved patient-reported genital psoriasis symptoms and impact of symptoms on sexual activity vs placebo in a randomized, double-blind study. J Sex Med. 2018;15(11):1645–1652. https://dx.doi.org/10.1016/j.jsxm.2018.09
- Gottlieb A.B., Kirby B., Ryan C., et al. The development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to assess the impact of genital psoriasis on sexual health. Dermatol Ther. 2018;8(1):33–44. https://dx.doi.org/10.1007/s13555-017-0212-3
- Felmingham C., Chan L., Doyle L.W., Veysey E. The Vulval Disease Quality of Life Index in women with vulval lichen sclerosus correlates with clinician and symptom scores. Australas J Dermatol. 2020;61(2):110–118. https://dx.doi.org/10.1111/ajd.13197
- Saunderson R.B., Harris V., Yeh R., et al. Vulvar quality of life index (VQLI) – a simple tool to measure quality of life in patients with vulvar disease. Australas J Dermatol. 2020;61(2):152–157. https://dx.doi.org/10.1111/ajd.1323
- Bunker C.B., Neill S.M. The genital, perianal and umbilical regions. In: Rook A., Burns T., Breathnach S.M., Cox N., Griffiths C.E., editors. Rook’s textbook of dermatology. Oxford: Blackwell Publishing; 2004.
- Lacarrubba F., Borghi A., Verzì A.E., et al. Dermoscopy of genital diseases: a review. J Eur Acad Dermatol Venereol. 2020;34(10):2198–2207. https://dx.doi.org/10.1111/jdv.16723
- Хрянин А.А., Соколовская А.В., Бочарова В.К. Псориаз в перианальной области: клинические проявления, дифференциальная диагностика и терапия. Фарматека. 2022;8(29):69–75 [Khryanin A.A., Sokolovskaya A.V., Bocharova V.K. Psoriasis in the perianal area: clinical manifestations, differential diagnosis and therapy. Farmateka. 2022;8(29):69–75. (In Russ)]. https://dx.doi.org/10.18565/pharmateca.2022.8.69-75
- Хрянин А.А., Соколовская А.В., Маркарьян Д.Р., и др. Заболевания кожи промежности и перианальной области. 2022, ГЭОТАР-Медиа, 192 с. [Khryanin A.A., Sokolovskaya A.V., Markaryan D.R., et al. Diseases of the skin of the perineum and perianal region. 2022, GEOTAR-Media, 192 p. (In Russ)].
- Borghi A., Virgili A., Corazza M. Dermoscopy of inflammatory genital diseases: practical insights. Dermatol Clin. 2018;36(4):451–461. https://dx.doi.org/10.1016/j.det.2018.05.013
- Omland S.H., Gniadecki R. Psoriasis inversa: a separate identity or a variant of psoriasis vulgaris? Clin Dermatol. 2015;33(4):456–461. https://dx.doi.org/10.1016/j.clindermatol.2015.04.007
- Bonnetblanc J-M. Psoriasis. Ann Dermatol Venereol. 2006;46(133):298?299. https://dx.doi.org/10.1016/S0151-9638(06)70902-4
- Shenenberger Dw. Curbing the psoriasis cascade: Therapies to minimize flares and frustration. Postgrad Med. 2005;117:9–16. https://dx.doi.org/10.3810/pgm.2005.05.1641
- Salim A., Wojnarowska F. Skin diseases affecting the vulva. Curr Obstet Gynaecol. 2002;12:81–89. https://dx.doi.org/10.1054/cuog.2001.0239
- Rook A., Burns T. Rook’s textbook of dermatology. 9th ed. Chichester, West Sussex (UK): Wiley Blackwell; 2016.
- Larsabal M., Ly S., Sbidian E., et al. GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis. Br J Dermatol. 2019;180(3):647–656. https://dx.doi.org/10.1111/bjd.17147
- Merola J.F., Bleakman A.P., Gottlieb A.B., et al. The Static Physician’s Global Assessment of Genitalia: a clinical outcome measure for the severity of genital psoriasis. J Drugs Dermatol. 2017;16(8):793–799.
- Gottlieb A.B., Kirby B., Ryan C., et al. The development of a patient-reported outcome measure for assessment of genital psoriasis symptoms: The Genital Psoriasis Symptoms Scale (GPSS). Dermatol Ther (Heidelb). 2018;8(1):45–56. https://dx.doi.org/10.1007/s13555-017-0213-2
- van der Meijden W.I., Boffa M.J., Ter Harmsel B., et al. 2021 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2022;36(7):952–972. https://dx.doi.org/10.1111/jdv.18102
- Zubrzycki N., Leow L.J. A Case of male genital psoriasis without involvement of the glans penis. Case Rep Dermatol. 2022;14(1):66–70. https://dx.doi.org/10.1159/000523818
- Butacu A.-I., Toma C., Negulet I.-E., et al. Updates on psoriasis in special areas. J Clin Med. 2024;13(24):7549. https://dx.doi.org/10.3390/jcm13247549
- Радионова Е.Е., Пирузян А.Л., Невозинская З.А., и др. Инверсный псориаз с поражением гениталий. Особенности клиники и терапии. Клиническая дерматология и венерология. 2020;19(2):206–212. [Radionova E.E., Piruzian A.L., Nevozinskaia Z.A., et al. Inverse psoriasis with genital lesions. Features of the clinic and therapy. Russian Journal of Clinical Dermatology and Venereology. 2020;19(2):206–212. (In Russ.)]. https://dx.doi.org/10.17116/klinderma202019021206
- Liao Y.H., Chiu H.C., Tseng Y.S., Tsai T.F. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Br J Dermatol. 2007;157(5):1005–1012. https://dx.doi.org/10.1111/j.1365-2133.2007.08201.x
- Khosravi H., Siegel M.P., Van Voorhees A.S., Merola J.F. Treatment of inverse/intertriginous psoriasis: updated guidelines from the Medical Board of the National Psoriasis Foundation. J Drugs Dermatol. 2017;16(8):760–766.
- Sarma N. Evidence and suggested therapeutic approach in psoriasis of difficult-to-treat areas: palmoplantar psoriasis, nail psoriasis, scalp psoriasis, and intertriginous psoriasis. Indian J Dermatol. 2017;62(2):113–122. https://dx.doi.org/10.4103/ijd.IJD_539_16
- Hashim P.W., Chima M., Kim H.J., et al. Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: a double-blind, randomized, vehicle-controlled trial. J Am Acad Dermatol. 2020;82(2):360–365. https://dx.doi.org/10.1016/j.jaad.2019.06.1288
- Draelos Z.D., Adam D.N., Hong H.C., et al. Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial. Br J Dermatol. 2023;188(6):810–812. https://dx.doi.org/10.1093/bjd/ljad060
- Lebwohl M.G., Stein Gold L., Strober B., et al. Phase 3 trials of tapinarof cream for plaque psoriasis. N Engl J Med. 2021;385(24):2219–2229. https://dx.doi.org/10.1056/NEJMoa2103629
- Reid C., Griffiths C.E.M. Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol. 2020;100(3):adv00032. https://dx.doi.org/10.2340/00015555-3386
- Corazza V., Cusano F., De Pità O., Rossi L., Virno G.G. Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines. Dermatol Reports. 2021 Dec 28;14(1):9454. https://dx.doi.org/10.4081/dr.2022.9454.
- Merola J.F., Parish L.C., Guenther L., et al. Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2024;90(3):485–493. https://dx.doi.org/10.1016/j.jaad.2023.10.020
- Menter A., Strober B.E., Kaplan D.H., et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029–1072. https://dx.doi.org/10.1016/j.jaad.2018.11.057
- Lee H.J., Kim M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 2023;24(17):13313. https://dx.doi.org/10.3390/ijms241713313
- Burlando M., Herzum A., Carmisciano L., et al. Biological therapy in genital psoriasis in women. Dermatol Ther. 2020;33(1):e13110. https://dx.doi.org/10.1111/dth.13110
Supplementary files
